The ASPS Plastic Surgery Statistics 2024 report was just released and offers a direct map of patient priorities, evolving expectations, and emerging gaps you can address to strategically grow your practice. Surgical Aesthetics 411 dives into the latest procedural stats and what it means for you.
Patients Keep Spending, But They’re Spending Smarter
Even in economic uncertainty, patients still prioritized aesthetic health in 2024. Demand held steady across surgical and minimally invasive procedures. But it’s not blind spending. Patients want treatments that integrate into wellness-focused lifestyles, emphasizing mental and physical benefits, not just “aesthetic luxury.”
This means patients are researching, comparing, and weighing value before they ever end up in your office. Practices that demonstrate safety, nuanced aesthetic judgment, and clear pre- and post-op planning will continue to stand out.
Ozempic Face is Real (And Driving Real Demand)
2024 marked the first time prescription weight loss medications were tracked in the ASPS report. These drugs are reshaping patients’ bodies and your consult pipeline. Skin laxity after semaglutide use has led to increased interest in neck lifts, facial procedures, arm lifts, thigh lifts, and abdominoplasties.
But these patients often come in metabolically altered, sometimes undernourished, with slower wound healing and higher anesthesia considerations. Optimizing patient selection, nutritional prehab, and counseling for realistic outcomes are now essential parts of post-weight loss body contouring protocols.
Top Surgical Winners: Contouring and Refinement Over Volume Alone
Liposuction remained the top surgical procedure, followed by breast augmentation, tummy tuck, breast lift, and eyelid surgery. The shift toward smaller, more proportionate implants while maintaining volume with fat grafting signals a patient preference for more subtle enhancement.
In breast work, augmentation is steady, but the quiet rise of the breast lift aligns with patients desiring lifted, natural shapes rather than simply increased volume. Combining lifts with moderate-volume implants or fat grafting can achieve these refined outcomes patients now expect.
Minimally Invasive Reigns, But It’s About More Than Botox
Injectables, fillers, and skin resurfacing dominate for good reason: low downtime, high satisfaction, and relatively low price points. But 2024’s data underscores a maturing patient population using these treatments preventatively and as maintenance between surgeries. Integrating high-quality injectable services in-house can improve patient retention while setting the stage for future surgical procedures.
Reconstructive Volumes Are Quietly Climbing
Reconstructive procedures saw the largest categorical growth at 2%. Tumor removal, hand surgery, breast reconstruction, maxillofacial procedures, and scar revision remain integral parts of the plastic surgeon’s skill set and income diversification.
Many aesthetic practices overlook the stability and professional satisfaction these cases bring. If your practice is heavily aesthetic, consider maintaining a portion of reconstructive caseload to balance economic cycles while reinforcing your comprehensive surgical skill positioning.
A Multi-Generational Market Awaits
Each age group brings distinct goals, concerns, and procedural preferences that can guide how you structure consultations, treatment planning, and patient education. Here’s a breakdown:
- Gen Z (20–29) is embracing injectables early, focusing on preventative care with subtle facial procedures.
- Millennials (30–39) continue to drive demand for breast procedures and body contouring while using neuromodulators for maintenance.
- Gen X (40–54) dominates aesthetic volumes, seeking comprehensive rejuvenation by combining surgical lifts with minimally invasive touch-ups.
- Baby Boomers (55–69) and 70+ remain highly active, investing in facial and neck rejuvenation to match their active lifestyles.
Targeted marketing and counseling strategies for each age group can optimize your pipeline, with combination therapy planning increasing per-patient value and outcomes.
Regional Flavor Shapes Demand
Regional data revealed some stark differences:
- South Atlantic sees heavy Brazilian butt lift and liposuction demand.
- Mountain/Pacific leads in cheek implants and buccal fat removal.
- New England prefers butt lifts and facial contouring.
- South Central has strong lower body lift demand.
- North Central patients favor chin augmentation and male breast reduction.
Know your region, align your procedure offerings accordingly, and ensure your digital presence reflects these local demands.
What You Can Do Now
- Audit Your Consults
How many post-weight loss patients are you seeing? Are you prepared to counsel and optimize these cases safely?
- Evaluate Your Injectable Integration
Is your practice capturing the growing minimally invasive demand, or are you letting medi-spas take these future surgical patients?
- Expand Reconstruction Strategically
Consider incorporating manageable reconstructive cases to diversify revenue and highlight your board certification.
- Segment Your Marketing
Align messaging with generational priorities to increase consultation conversions.
- Align With Safety Messaging
The ASPS continues to position board-certified surgeons as the gold standard. Leverage this in your patient communications to differentiate yourself in a crowded market.
The Data Says: Adaptation Wins
The ASPS 2024 report shows patients will continue to invest in aesthetic and reconstructive surgery regardless of economic climates, but they will invest wisely. Combining safe, advanced surgical techniques with strategic practice management and patient-centered education will keep your practice competitive. Stay adaptable, stay visible, and continue prioritizing the people behind the numbers.
Surgical Aesthetics 411 will continue to track the science, the products, and the legal landscape so you don’t have to. Subscribe to stay ahead of the curve, cut through the marketing, and make smarter decisions in your aesthetics practice.
SOURCES: ASPS
